BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 22555525)

  • 21. A comparison of ThinPrep Imager-assisted with manual screening, and its place in the New Zealand cervical cancer screening program.
    Yeong ML; Pringle E; Stewart J; Retter E
    Pathology; 2013 Aug; 45(5):474-7. PubMed ID: 23856838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary report on monolayer preparation of cervical sample by indigenous technique.
    Sharma S; Dey P
    Diagn Cytopathol; 2020 Dec; 48(12):1318-1321. PubMed ID: 32735389
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pap test: liquid-based--thin-layer. A new method: results].
    Hammou JC; Bertino B; Blancheri A; Kon Man P; Patoz L
    Gynecol Obstet Fertil; 2003 Oct; 31(10):833-40. PubMed ID: 14642940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of abnormalities in gynecologic cytopathology with deep learning.
    Ke J; Shen Y; Lu Y; Deng J; Wright JD; Zhang Y; Huang Q; Wang D; Jing N; Liang X; Jiang F
    Lab Invest; 2021 Apr; 101(4):513-524. PubMed ID: 33526806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous atypia in the atrophic cervical vaginal smear: a plea for a more painstaking old style look versus a new look at the old problem.
    Medley G; Surtees VM
    Cancer; 1998 Aug; 84(4):200-1. PubMed ID: 9723593
    [No Abstract]   [Full Text] [Related]  

  • 26. Utility of histiocytic immunomarkers in differentiating histiocytic aggregates with marked nuclear atypia from high grade squamous intraepithelial lesions in liquid-based cervicovaginal cytology specimens.
    Giorgadze T; Miller LE; Preiszner J; Nassar A
    Acta Cytol; 2009; 53(4):479-81. PubMed ID: 19697743
    [No Abstract]   [Full Text] [Related]  

  • 27. Concanavalin A-peroxidase labeling in cervical exfoliative cytopathology. II. Routine assessment of labeling results.
    Davina JH; Stadhouders AM; van Haelst UJ; de Graaf R; Kenemans P
    Gynecol Oncol; 1985 Oct; 22(2):224-32. PubMed ID: 4054719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing "blue blobs". Immunohistochemical staining and ultrastructural study.
    Abdulla M; Hombal S; Kanbour A; Becich M; Stankovich D; Ries A; Kanbour-Shakir A
    Acta Cytol; 2000; 44(4):547-50. PubMed ID: 10934947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Architectural aspects of cell-blocks as small biopsies.
    Satturwar S; Pantanowitz L
    Cytojournal; 2021; 18():5. PubMed ID: 33880128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limitations on the detection rate of high-risk HPV by hybrid capture 2 methodology in high grade intraepithelial (HSIL) or atypical squamous cells-cannot exclude HSIL (ASC-H) cytological lesions with proved CIN2.
    Noël JC; Simon P
    Anal Cell Pathol (Amst); 2015; 2015():746502. PubMed ID: 26421258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pap test and Bethesda 2014.
    Nayar R; Wilbur DC
    Cancer Cytopathol; 2015 May; 123(5):271-81. PubMed ID: 25931431
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of high-grade lesions on cell blocks from residual fluids of Pap smears diagnosed as low-grade abnormalities: a preliminary pilot study.
    Catteau X; Simon P; Noël JC
    Acta Cytol; 2012; 56(3):247-50. PubMed ID: 22555525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
    Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
    J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
    Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
    Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.